Zhitong Finance App News, Lepu Healthcare (300003.SZ) issued an announcement. The company learned today that the company's holding subsidiary Shanghai Minwei Biotechnology Co., Ltd. (“Shanghai Minwei Biotech”) has received the “Drug Clinical Trial Approval Notice” (Notice Number: 2026LP03439) approved and issued by the State Drug Administration, and the MWX205 injection clinical trial application declared by Shanghai Minwei Biology has been approved.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.